Alpha Tau Medical (DRTS) Cash from Investing Activities (2021 - 2022)
Alpha Tau Medical's (DRTS) quarterly Cash from Investing Activities came in at -$92.4 million in Q2 2022, down 30898.99% quarter-over-quarter from -$298000.0 in Q1 2022.
Alpha Tau Medical (DRTS) Cash from Investing Activities (2021 - 2022) Analysis & Trends
Alpha Tau Medical has disclosed Cash from Investing Activities across 2 years of filings, most recently posting -$92.4 million for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 579,519.10 |
| 10 | Alpha Tau Medical | 2,384.20 | -76.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -92.38 Mn |
| Jun 30, 2022 | -92.38 Mn |
| Mar 31, 2022 | -298,000.00 |
| Mar 31, 2022 | -298,000.00 |
| Mar 31, 2021 | -609,000.00 |
| Mar 31, 2021 | -609,000.00 |